BASEL (dpa-AFX) - Ligand Pharmaceuticals Incorporated (LGND) announced that
the FDA has approved a supplemental New Drug Application (sNDA) for the use of
Promacta (eltrombopag), a Novartis product, for the treatment of children six
WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc. (LGND) Friday announced
that its partner, GlaxoSmithKline Plc (GSK.L, GSK), presented results from Phase
3 study of eltrombopag in pediatric patients with chronic immune...
Comtech EF Data Corp. announced today that it was once again named the
largest Single Channel per Carrier (SCPC) satellite modem supplier in
the COMSYS VSAT Report, 13th Edition.
The recently published report identifies...
Students graduate college with accounting degrees, but that doesn’t mean they’re ready to be accountants. I spoke with Ben Mulling, CMA, CPA, CITP, who became CFO of TENTE Casters Inc. at the age of 28, about the gap between what students...
MILTON KEYNES, England
, Sept. 5, 2012 /PRNewswire/ -- In his keynote speech at this year's Comsys VSAT2012 conference in
, Hughes President,
, will present the company's vision to expand its successful...
The Securities and Exchange Commission has charged the close friend of a CEO with insider trading in the stock of a Houston-based employment services company by exploiting confidential information he learned while they were spending time ...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.